share_log

Moderna shares are trading higher after French health officials on Thursday said an mRNA vaccine can be used in place of the second shot from AstraZeneca. Additionally, White House COVID-19 Response C

Moderna shares are trading higher after French health officials on Thursday said an mRNA vaccine can be used in place of the second shot from AstraZeneca. Additionally, White House COVID-19 Response C

在法国卫生官员周四表示，可以使用mRNA疫苗来取代阿斯利康(AstraZeneca)的第二针疫苗后，现代股票交易走高。此外，白宫新冠肺炎回应C
Benzinga ·  2021/04/09 23:24

Moderna shares are trading higher after French health officials on Thursday said an mRNA vaccine can be used in place of the second shot from AstraZeneca. Additionally, White House COVID-19 Response Coordinator Jeff Zients recently said the US in on track of meeting the goal of 100 million shots in 100 days.

在法国卫生官员周四表示，可以使用mRNA疫苗来取代阿斯利康(AstraZeneca)的第二针疫苗后，现代股票交易走高。此外，白宫新冠肺炎回应协调员杰夫·齐恩茨最近表示，美国有望在100天内实现1亿次拍摄的目标。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发